Forschung in Hamburg - ©
Ebola © National Institute of Allergy and Infectious Diseases (NIAID), NIH

Success In Ebola Research

Scientists from Hamburg's Heinrich Plette Institute succeed in generating animal model. Mouse model allows advanced research

The development of treatments for Ebola virus disease (EVD) has been hampered by the lack of small animal models that mimick human disease. Now, a group of scientists at Hamburg’s Heinrich Pette Institute headed by Dr. César Muñoz-Fontela succeeded in generating a small animal model with human components for the development of EVD therapies. Their model showed that mice transplanted with human hematopoetic stem cells reproduce typical features of EVD. Infection with Ebola virus was associated with viremia, cell damage, liver steatosis, signs of hemorrhage, and high lethality.

Veröffentlichung: Ebola virus disease in mice transplanted with human hematopoietic stem cells. J Virol. 2015 Feb 11. pii: JVI.03546-14.

More articles

  • There are no older articles in this category.
  • There are no newer articles in this category.